<DOC>
	<DOCNO>NCT01469377</DOCNO>
	<brief_summary>An outpatient study evaluate safety efficacy cariprazine adjunct Antidepressant Therapy ( ADT ) patient Major Depressive Disorder ( MDD ) inadequate response antidepressant alone . This clinical study compare cariprazine + ADT placebo + ADT outpatient diagnosis MDD inadequate response ADT current episode . The study consist approximately 2 week screen washout follow 8 week double-blind treatment follow 1 week safety follow-up .</brief_summary>
	<brief_title>Safety Efficacy Cariprazine Adjunctive Antidepressant Therapy Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Male female outpatient 18 65 year age , inclusive Currently meet Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) criteria moderate severe MDD Current major depressive episode least 8 week exceed 24 month duration Ongoing inadequate response protocol allow ADT Principal DSMIVTRbased diagnosis axis I disorder , MDD , Women pregnant , plan become pregnant breastfeed study practice reliable contraception continue study History meeting DSMIVTR criterion : 1 . Depressive episode psychotic catatonic feature 2 . Manic , hypomanic mixed episode , include bipolar disorder substance induce manic , hypomanic mixed episode 3 . Schizophrenia , schizoaffective , psychotic disorder 4 . Obsessivecompulsive disorder 5 . Bulimia anorexia nervosa 6 . Dementia , amnesic , cognitive disorder 7 . Mental retardation Patients consider suicide risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
</DOC>